中国医疗前沿
中國醫療前沿
중국의료전연
CHINA HEALTHCARE INNOVATION
2013年
8期
25-26
,共2页
李雄%罗爱华%吴辉耀%吴祖扬%张武
李雄%囉愛華%吳輝耀%吳祖颺%張武
리웅%라애화%오휘요%오조양%장무
肝炎%乙型%病毒量%血清学%病理学
肝炎%乙型%病毒量%血清學%病理學
간염%을형%병독량%혈청학%병이학
Hepatitis%Hepatitis B%Viral load%Serology%Pathology
目的研究慢性乙肝患者病毒量及血清学标志与病理指标相关性.方法选取29例乙肝患者,经确诊均具有血清学标志阳性反复肝功能异常,对其实施肝穿刺免疫组化和病理检查、血清肝炎病毒学监测、凝血功能检查和肝功能检查,采用荧光定量PCR方法对患者血清乙肝病毒DNA(HBV DNA)含量进行检测.结果经过对肝脏纤维化分期和炎症分级各组的血清HBV DNA定量水平进行比较发现,其差异均无统计学意义(P>0.05);HBV DNA的阴性和阳性患者在各项病理指标方面的差异也不具有统计学意义(P>0.05);对非乙肝患者与乙肝患者之间的相关数据指标进行比较后发现,其差异性不具有统计学意义(P>0.05).结论随着临床病情的变化,慢性病毒性肝炎患者的血清学标志与肝脏纤维化病理也随之改变.采用血清学指标与肝组织活检的综合检测方法具有较高的临床诊断价值.
目的研究慢性乙肝患者病毒量及血清學標誌與病理指標相關性.方法選取29例乙肝患者,經確診均具有血清學標誌暘性反複肝功能異常,對其實施肝穿刺免疫組化和病理檢查、血清肝炎病毒學鑑測、凝血功能檢查和肝功能檢查,採用熒光定量PCR方法對患者血清乙肝病毒DNA(HBV DNA)含量進行檢測.結果經過對肝髒纖維化分期和炎癥分級各組的血清HBV DNA定量水平進行比較髮現,其差異均無統計學意義(P>0.05);HBV DNA的陰性和暘性患者在各項病理指標方麵的差異也不具有統計學意義(P>0.05);對非乙肝患者與乙肝患者之間的相關數據指標進行比較後髮現,其差異性不具有統計學意義(P>0.05).結論隨著臨床病情的變化,慢性病毒性肝炎患者的血清學標誌與肝髒纖維化病理也隨之改變.採用血清學指標與肝組織活檢的綜閤檢測方法具有較高的臨床診斷價值.
목적연구만성을간환자병독량급혈청학표지여병리지표상관성.방법선취29례을간환자,경학진균구유혈청학표지양성반복간공능이상,대기실시간천자면역조화화병리검사、혈청간염병독학감측、응혈공능검사화간공능검사,채용형광정량PCR방법대환자혈청을간병독DNA(HBV DNA)함량진행검측.결과경과대간장섬유화분기화염증분급각조적혈청HBV DNA정량수평진행비교발현,기차이균무통계학의의(P>0.05);HBV DNA적음성화양성환자재각항병리지표방면적차이야불구유통계학의의(P>0.05);대비을간환자여을간환자지간적상관수거지표진행비교후발현,기차이성불구유통계학의의(P>0.05).결론수착림상병정적변화,만성병독성간염환자적혈청학표지여간장섬유화병리야수지개변.채용혈청학지표여간조직활검적종합검측방법구유교고적림상진단개치.
Objective In patients with chronic hepatitis b virus and serological sign and pathological correlation study. Methods Select 29 patients with hepatitis b, confirmed have positive serological marker repeated abnormal liver function, liver puncture by the immunohistochemical and pathologic examination of serum hepatitis virology monitoring blood coagulation function and liver function tests,adopting fluorescence quantitative polymerase chain reaction(PCR) in serum of patients with hepatitis b virus DNA(HBV DNA) levels were detected. Result Through to the staging of liver fibrosis and inflammation grading comparison between groups of serum HBV DNA level of quantitative detection. The differences were not statistically significant(P>0.05); HBV DNA negative and positive in all patients with pathological indicators did not appear obvious difference, not statistically significant(P>0.05); For hepatitis b patients and hepatitis b patients between related data index found after comparison, the difference is not statistically significant(P>0.05). Conclusion As the change of clinical symptoms, the serological marker of patients with chronic viral hepatitis liver fibrosis pathological change. Adoption of serological indexes and liver biopsy comprehensive detection method has higher diagnosis value.